PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Short Interest Down 61.3% in February

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 21,300 shares, a decline of 61.3% from the January 31st total of 55,000 shares. Based on an average daily volume of 154,800 shares, the days-to-cover ratio is currently 0.1 days.

PreveCeutical Medical Stock Down 2.1 %

OTCMKTS:PRVCF traded down $0.00 during trading hours on Friday, hitting $0.02. 46,605 shares of the stock were exchanged, compared to its average volume of 160,844. PreveCeutical Medical has a twelve month low of $0.01 and a twelve month high of $0.03. The company’s 50 day moving average is $0.02 and its two-hundred day moving average is $0.02.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.